Lung microdialysis study of levofloxacin in rats following intravenous infusion at steady state

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 9, 2008, Pages 3074-3077

  Marchand, Sandrine ^a,b,c   Frasca, Denis ^a,c   Dahyot Fizelier, Claire ^a,c   Breheret, Céline ^b   Mimoz, Olivier ^a,b,c   Couet, William ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ DE POITIERS   (France)

^c POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; LEVOFLOXACIN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD; CALIBRATOR; CONTROLLED STUDY; DIALYSATE; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LUNG; MALE; MICRODIALYSIS; MUSCLE; NONHUMAN; PRIORITY JOURNAL; RAT; STEADY STATE;

ANIMALS; ANTI-BACTERIAL AGENTS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; INFUSIONS, INTRAVENOUS; LUNG; MALE; MICRODIALYSIS; MUSCLE, SKELETAL; OFLOXACIN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 50949091842     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00242-08     Document Type: Article

References (25)

1. Bellmann, R., G. Kuchling, P. Dehghanyar, M. Zeitlinger, E. Minar, B. X. Mayer, M. Müller, and C. Joukhadar. 2004. Tissue pharmacokinetics of levofloxacin in human soft tissue infections. Br. J. Clin. Pharmacol. 57:563-568.
2. Boselli, E., D. Breilh, S. Djabarouti, C. Guillaume, T. Rimmelé, J. B. Gordien, F. Xuereb, M. C. Saux, and B. Allaouchiche. 2007. Reliability of mini-bronchoalveolar lavage for the measurement of epithelial lining fluid concentrations of tobramycin in critically ill patients. Intensive Care Med. 33:1519-1523.
3. Conte, J. E., Jr., J. A. Golden, M. G. Kelley, and E. Zurlinden. 2005. Intrapulmonary pharmacokinetics and pharmacodynamics of meropenem. Int. J. Antimicrob. Agents 26:449-456.
4. Conte, J. E., Jr., J. A. Golden, M. McIver, and E. Zurlinden. 2006. Intrapulmonary pharmacokinetics and pharmacodynamics of high-dose levofloxacin in healthy volunteer subjects. Int. J. Antimicrob. Agents 28:114-121.
5. Conte, J. E., Jr., J. A. Golden, M. McIver, E. Little, and E. Zurlinden. 2007. Intrapulmonary pharmacodynamics of high-dose levofloxacin in subjects with chronic bronchitis or chronic obstructive pulmonary disease. Int. J. Antimicrob. Agents 30:422-427.
6. Dahyot, C., S. Marchand, G. L. Pessini, C. Pariat, B. Debaene, W. Couet, and O. Mimoz. 2006. Microdialysis study of imipenem distribution in skeletal muscle and lung extracellular fluids of Acinetobacter baumannii-infected rats. Antimicrob. Agents Chemother. 50:2265-2267.
7. Dahyot, C., S. Marchand, M. Bodin, B. Debaene, O. Mimoz, and W. Couet. 2008. Application of basic pharmacokinetic concepts to analysis of microdialysis data: illustration with imipenem muscle distribution. Clin. Pharmacokinet. 47:181-189.
8. de Lange, E. C., S. Marchand, D. van den Berg, I. C. van der Sandt, A. G. de Boer, A. Delon, S. Bouquet, and W. Couet. 2000. In vitro and in vivo investigations on fluoroquinolones: effects of the P-glycoprotein efflux transporter on brain distribution of sparfloxacin. Eur. J. Pharm. Sci. 12:85-93.
9. de la Peña, A., T. Dalla Costa, J. D. Talton, E. Rehak, J. Gross, U. Thyroff-Friesinger, A. I. Webb, M. Müller, and H. Derendorf. 2001. Penetration of cefaclor into the interstitial space fluid of skeletal muscle and lung tissue in rats. Pharm. Res. 18:1310-1314.
10. Edwards, J. E., K. R. Brouwer, and P. J. McNamara. 2002. GF120918, A P-glycoprotein modulator, increases the concentration of unbound amprenavir in the central nervous system in rats. Antimicrob. Agents Chemother. 46:2284-2286.
11. Endter, S., U. Becker, N. Daum, H. Huwer, C. M. Lehr, M. Gumbleton, and C. Ehrhadt. 2007. P-glycoprotcin (MDR1) functional activity in human alveolar epithelial cell monolayers. Cell Tissue Res. 328:77-84.
12. Granero, L., M. Santiago, J. Cano, A. Machado, and J. E. Peris. 1995. Analysis of ceftriaxone and ceftazidime distribution in cerebrospinal fluid of and cerebral extracellular space in awake rats by in vivo microdialysis. Antimicrob. Agents Chemother. 39:2728-2731.
13. Hutschala, D., K. Skhirtladze, A. Zuckermann, W. Wisser, P. Jaksch, B. X. Mayer-Helm, H. Burgmann, E. Wolner, M. Müller, and E. M. Tschernko. 2005. In vivo measurement of levofloxacin penetration into lung tissue after cardiac surgery. Antimicrob. Agents Chemother. 49:5107-5111.
14. Kiem, S., and J. J. Schentag. 2008. Interpretation of antibiotic concentration ratios measured in epithelial lining fluid. Antimicrob. Agents Chemother. 52:24-36.
15. Leslie, E. M., R. G. Deeley, and S. P. Cole. 2005. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol. Appl. Pharmacol. 204:216-237.
16. Liu, P., M. Muller, M. Grant, A. I. Webb, B. Obermann, and H. Derendorf. 2002. Interstitial tissue concentrations of cefpodoxime. J. Antimicrob. Chemother. 50(Suppl):19-22.
17. Marchand, S., M. Chenel, I. Lamarche, C. Pariat, and W. Couet. 2003. Dose ranging pharmacokinetics and brain distribution of norfloxacin using microdialysis in rats. J. Pharm. Sci. 92:2458-2465.
18. Marchand, S., C. Dahyot, I. Lamarche, O. Mimoz, and W. Couet. 2005. Microdialysis study of imipenem distribution in skeletal muscle and lung extracellular fluids of noninfected rats. Antimicrob. Agents Chemother. 49: 2356-2361.
19. Mouton, J. W., U. Theuretzbacher, W. A. Craig, P. M. Tulkens, H. Derendorf, and O. Cars. 2008. Tissue concentrations: do we ever learn? J. Antimicrob. Chemother. 61:235-237.
20. National Institutes of Health. 1985. Principles of laboratory animal care. NIH publication 85-23. National Institutes of Health, Bethesda, MD.
21. Scheffer, G. L., A. C. Pijnenborg, E. F. Smit, M. Müller, D. S. Postma, W. Timens, P. van der Valk, E. G. de Vries, and R. J. Scheper. 2002. Multidrug resistance related molecules in human and murine lung. J. Clin. Pathol. 55:332-339.
22. Steimer, A., H. Franke, E. Haltner-Ukomado, M. Laue, C. Ehrhardt, and C. M. Lehr. 2007. Monolayers of porcine alveolar epithelial cells in primary culture as an in vitro model for drug absorption studies. Eur. J. Pharm. Biopharm. 66:372-382.
23. Zeitlinger, M., M. Müller, and C. Joukhadar. 2005. Lung microdialysis - a powerful tool for the determination of exogenous and endogenous compounds in the lower respiratory tract. AAPS J. 7:E600-E608.
24. Zeitlinger, M. A., P. Dehghanyar, B. X. Mayer, B. S. Schenk, U. Neckel, G. Heinz, A. Georgopoulos, M. Müller, and C. Joukhadar. 2003. Relevance of soft-tissue penetration by levofloxacin for target site bacterial killing in patients with sepsis. Antimicrob. Agents Chemother. 47:3548-3553.
25. Zeitlinger, M. A., F. Traunmüller, A. Abrahim, M. R. Müller, Z. Erdogan, M. Müller, and C. Joukhadar. 2007. A pilot study testing whether concentrations of levofloxacin in interstitial space fluid of soft tissues may serve as a surrogate for predicting its pharmacokinetics in lung. Int. J. Antimicrob. Agents 29:44-50.